Search

everythinglearnresearchcommunity

for

Search:↓

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib improved hair loss and arthritis in a lupus patient.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Upadacitinib may cause hair loss.

Gefitinib can cause hair and eyebrow darkening.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

A new compound shows promise as a topical treatment for hair loss.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

CS12192 effectively treats alopecia areata with better safety than current options.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Rituximab may cause skin issues, but baricitinib can help improve them.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Nilotinib may cause gray hair to return to its original color.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.